Variables | Overall | Unrevascularized (n = 28) | Revascularized (n = 143) | P1 value | iP2 value | |
---|---|---|---|---|---|---|
CSB (n = 100) | F-TEVAR (n = 43) | |||||
30-day outcomes, n | 171 | 28 | 100 | 43 | ||
Mortality (N, %) | 1, 0.6% | 1, 3.6% | 0, 0% | 0, 0% | 0.164 | _ |
Stroke (N, %) | 2, 1.2% | 0, 0% | 2, 2.0% | 0, 0% | 1 | 1 |
Left upper extremity ischemia (N, %) | 2, 1.2% | 0, 0% | 2, 2% | 0, 0% | 1 | 1 |
Spinal cord ischemia (N, %) | 5, 2.9% | 3, 10.7% | 1, 1.0% | 1, 2.3% | 0.032* | 0.512 |
Midterm outcomes, n | 167 | 26 | 100 | 41 | ||
Mortality (N, %) | 10, 6.0% | 2, 7.7% | 8, 8% | 0, 0% | 1 | 0.143 |
Stroke (N, %) | 9, 5.4% | 3, 11.5% | 4, 4.0% | 2, 4.9% | 0.299 | 1 |
Left upper extremity ischemia (N, %) | 12, 7.2% | 4, 15.4% | 6, 6.0% | 2, 4.9% | 0.177 | 1 |
Spinal cord ischemia (N, %) | 0, 0% | 0, 0% | 0, 0% | 0, 0% | _ | _ |